Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0004 Transporter Info | ||||
| Gene Name | ABCG2 | ||||
| Transporter Name | Breast cancer resistance protein | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Ritonavir Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 392622 | ||||
| Docking Score | -11.656 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C37H48N6O5S2 | ||||
| Molecular Weight | 720.9 | ||||
| Canonical SMILES |
CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
|
||||
| InChI |
InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1
|
||||
| InChIKey | NCDNCNXCDXHOMX-XGKFQTDJSA-N | ||||
| Pharmaceutical Properties | Xlogp | 6 | Rotatable Bond Count | 18 | |
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 9 | ||
| Xenobiotic Name | Delavirdine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 5625 | ||||
| Docking Score | -11.598 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H28N6O3S | ||||
| Molecular Weight | 456.6 | ||||
| Canonical SMILES |
CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C
|
||||
| InChI |
InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3
|
||||
| InChIKey | WHBIGIKBNXZKFE-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.4 | Rotatable Bond Count | 6 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Gefitinib Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 123631 | ||||
| Docking Score | -11.511 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C22H24ClFN4O3 | ||||
| Molecular Weight | 446.9 | ||||
| Canonical SMILES |
COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
|
||||
| InChI |
InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
|
||||
| InChIKey | XGALLCVXEZPNRQ-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.1 | Rotatable Bond Count | 8 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 8 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.